Phase 1, Open-Label Study to Evaluate Potential Pharmacokinetic Interactions Between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects.
Latest Information Update: 20 Aug 2023
At a glance
- Drugs Oseltamivir (Primary) ; Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 28 May 2010 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov (NCT00540501).
- 28 May 2010 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov (NCT00540501).
- 20 Mar 2010 Actual patient number (17) added as reported by ClinicalTrials.gov (NCT00921726).